NALOXONE HYDROCHLORIDE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
51662-1586 -
Package NDC
51662-1586-1 -
Package NDC
51662-1586-3 -
Application number
ANDA213279 -
SPL ID
0ffa7c10-a9fe-7701-e063-6394a90a06cf -
SPL set ID
e65e03c1-9a66-b30b-e053-2995a90aeb73 -
UNII
F850569PQR -
RxCUI
1191250
What the source publishes
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Active ingredients
- NALOXONE HYDROCHLORIDE
- Form
- INJECTION, SOLUTION
- Routes
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "NALOXONE HYDROCHLORIDE",
"splId": "0ffa7c10-a9fe-7701-e063-6394a90a06cf",
"labels": [
{
"setId": "e65e03c1-9a66-b30b-e053-2995a90aeb73",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e65e03c1-9a66-b30b-e053-2995a90aeb73",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e65e03c1-9a66-b30b-e053-2995a90aeb73"
}
],
"routes": [
"INTRAMUSCULAR",
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"labeler": "HF Acquisition Co LLC, DBA HealthFirst",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE in 1 BOX (51662-1586-1) / 2 mL in 1 SYRINGE",
"package_ndc": "51662-1586-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20220816"
},
{
"sample": false,
"description": "10 POUCH in 1 CASE (51662-1586-3) / 1 BOX in 1 POUCH (51662-1586-2) / 1 SYRINGE in 1 BOX / 2 mL in 1 SYRINGE",
"package_ndc": "51662-1586-3",
"identifierStatus": "well-formed",
"marketing_start_date": "20220816"
}
],
"productId": "51662-1586_0ffa7c10-a9fe-7701-e063-6394a90a06cf",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "51662-1586",
"deaSchedule": null,
"genericName": "NALOXONE HYDROCHLORIDE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NALOXONE HYDROCHLORIDE",
"strength": "1 mg/mL"
}
],
"applicationNumber": "ANDA213279",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220816",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"F850569PQR"
],
"rxcui": [
"1191250"
],
"spl_set_id": [
"e65e03c1-9a66-b30b-e053-2995a90aeb73"
],
"manufacturer_name": [
"HF Acquisition Co LLC, DBA HealthFirst"
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:51662-1586_0ffa7c10-a9fe-7701-e063-6394a90a06cf"